Is the Surge in Respiratory Syncytial Virus Related to the COVID-19 Pandemic? A Clinical-Based Review
Shelley Khabieh*, Farage Ftiha and Albert Bassoul
1The City University of New York - Brooklyn College, Brooklyn, New York, USA
2Avenue U Paediatrics, Brooklyn, New York, USA
3New York Institute of Technology College of Osteopathic Medicine, Old Westbury, NY, US
Citation: Khabieh S, Ftiha F, Bassoul A
(2021) Is the Surge in Respiratory Syncytial Virus Related to the COVID-19 Pandemic? A Clinical-Based Review. SciTech Immuno-Microbiology 2021
Received: September 02, 2021 Accepted: September 06, 2021 Published: September 06, 2021
Abstract
Respiratory syncytial virus (RSV) has been around for many years. Symptoms of the virus includes: cough, runny nose, loss of appetite, and a possible ear infection. Often times, the patient presents with bronchiolitis, which eventually escalates to RSV. Children most commonly affected by RSV are between the ages of 0-2. In December 2019, the first case of SARS-CoV-2 was discovered in China. Normally, the RSV virus sparks around the winter months; however, throughout the COVID -19 pandemic, RSV was at its all-time low. When SARS-CoV-2 started to decline in early April 2021, there was a spike in the respiratory syncytial virus among children.
Keywords: Respiratory syncytial virus, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2, Pediatrics, Virology, Pathology
